-+ 0.00%
-+ 0.00%
-+ 0.00%

Concentrix (CNXC) Stock Shrugs Off $1.05b Write Down As Cash Flow Holds

Simply Wall St·10/01/2026 01:20:19
语音播报

Concentrix stock barely budged today, up less than 1%, even after posting headline numbers that would usually move a customer experience outsourcer much more. The headline is not the tiny price move; it is a large reported loss driven by a roughly US$1.05b non cash goodwill impairment that reduced GAAP earnings, while underlying non GAAP profitability came in ahead of guidance.

Short term traders see a flat chart after a weak month. Longer term holders are looking at a business supported by record free cash flow, paying down debt and working to rebuild credibility after substantial write downs.

Is Concentrix a rare bargain at a 0.2x P/S, or is the steep discount simply mirroring its large reported losses and weak coverage of interest and dividends? See how that trade off looks in our valuation analysis for Concentrix

Q3 2026 Earnings Summary

  • Revenue, Q3 2026 vs. Q3 2025: US$2,453.7m vs. US$2,483.3m (slight decline in quarterly sales)
  • Net Income, Q3 2026 vs. Q3 2025: loss of US$988.1m vs. profit of US$83.9m (swing into a large quarterly loss, primarily due to non cash goodwill impairment)
  • Basic EPS, Q3 2026 vs. Q3 2025: loss of US$16.22 per share vs. earnings of US$1.34 per share (sharp deterioration in reported quarterly earnings per share)
  • Adjusted EBITDA Margin, Q3 2026 vs. Q3 2025: 14.8% vs. 14.5% (modest expansion in adjusted earnings before interest, tax, depreciation and amortization, or EBITDA, margin)

Prefer clean charts instead of another wall of dense earnings text and tables for Concentrix? See the full visual breakdown of the business, with a focus on its valuation picture at a glance, in our company report for Concentrix.

NasdaqGS:CNXC Trailing 12-Month Revenue & Expenses Breakdown as at Oct 2026
NasdaqGS:CNXC Trailing 12-Month Revenue & Expenses Breakdown as at Oct 2026

Concentrix bullish AI story meets mixed proof

Bulls argue Concentrix is quietly swapping low value call centers for higher margin, AI led CX and that this will show up first in profitability and cash generation. Q3 does back part of that claim. Non GAAP operating margin ticked up to 12.6% and adjusted EBITDA margin reached 14.8%, both 30 bps higher year on year, even though constant currency revenue slipped about 0.5%. Record Q3 free cash flow of US$218m and US$211m of debt reduction point to a model that is throwing off cash while investing in iX Suite and GenAI deployments. Management also flagged that more than half of revenue now comes from business created or transformed in the last three years. What this quarter does not yet show is AI led growth, since guidance still calls for a modest top line decline for both Q4 and the full year.

Bearish concerns on growth, leverage and clients

The bear story centers on weak growth, heavy goodwill, leverage and hyperscaler risk overwhelming the AI pitch. Q3 numbers back several of those worries. Revenue came in slightly below constant currency guidance and management now expects Q4 sales to fall 3% to 5%, with full year revenue also drifting down. A US$1.05b goodwill impairment tied to share price pressure kept the headline loss front and center and reminds you how much past deal value is still on the books. Hyperscaler pullbacks are set to hit revenue in Q4 and early 2027 and shore mix changes are already creating about a 3 percentage point drag. Client budget shifts and offshoring are not just theory. They are visible in the outlook. Debt is moving lower, but interest and leverage remain a live constraint on buybacks and EPS support.

Compare Concentrix's record free cash flow and margin expansion with the flat share price reaction and ask a simple question: see whether analysts think this operational progress really earns a re‑rating or if they are cutting back their expectations in the consensus price target analysis for Concentrix

Take Control Of Your Next Move

If Concentrix's mix of record free cash flow, goodwill write downs and a 0.2x P/S has you interested but cautious, register for free with Simply Wall St and add it to a Watchlist to track price against fair value and spot a potential entry that actually fits your plan. Once you decide to own it, keep your decisions grounded in data by using the Portfolio Command Center to cut through noise and focus on key developments that matter to your holdings. For a broader view on what other investors are seeing in Concentrix and similar stocks, tap into the Community to weigh different theses and risks. That combination may help you surface hidden catalysts and warning signs early so you can stay a step ahead of the market.

Seeking Alternatives Before Momentum Flies

Fresh ideas move first. Stocks do not wait while you hesitate. Spot potential breakout trends under the radar for now and act before the crowd. Get in early.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.